MAP1A and pancreatic neoplasm: According to the GEPIA analysis based on TCGA, similar to AGTPBP1, the expression of MYLK and MAP1A in pancreatic cancer tissues was significantly upregulated (Fig. 6A and B) (P < 0.05).